| Clinical data | |
|---|---|
| Other names | 17β-((6-Hydroxyhexyl)amino)estradiol; 17β-[(6-Hydroxyhexyl)amino]estra-1,3,5(10)-trien-3-ol; N-(3-Hydroxy-1,3,5(10)-estratrien 17-yl)-6-hydroxyhexylamine |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C24H37NO2 |
| Molar mass | 371.565 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Hexolame, also known as17β-((6-hydroxyhexyl)amino)estradiol, is asynthetic,steroidalestrogen and a17β-aminoestrogen withanticoagulant effects that was first described in 1990 and was never marketed.[1][2][3]
Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it. |